| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.03 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |